High materiality7/10
Recursion Pharmaceuticals price target raised to $5.90 from $5.30 at Morgan Stanley
Why it may matterVerify against the original reporting
Buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises Recursion Pharmaceuticals target to $5.90 from $5.30. Current price is $3.77. Upside remains despite a price drop of about 7.97% since the signal.
- Target vs price: $5.90 vs $3.77
- Price: $3.77
- Price change since signal: -7.97%
Key facts
- 01
Target: $5.9
- 02
Posted price: $3.77
- 03
Analyst firm: Morgan Stanley
- 04
Analyst: Sean Laaman
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.